Professional Documents
Culture Documents
Olmesartan Drug Study
Olmesartan Drug Study
Olmesartan Drug Study
Dosage: Hypertension
Adult: PO 20 mg q. d. may increase to 40 mg q.d. start with 5-10 mg q.d. if volume depleted
Mode of Action: Angiotensin II receptor (type AT1) antagonist acts as a potent vasodilator and primary
vasoactive hormone of the rennin-angiotensin-aldosterone system. Selectively blocks the binding of
angiotensin II to the AT 1 receptors found in many tissues (e.g., vascular smooth muscle, adrenal glands).
Antihypertensive effects results from blocking the vasoconstricting and aldosterone-secreting effects of
angiotensin II. Antihypertensive effect is due to its potent vasodilation effect.
Drug-Drug Interaction: may increase hypotensive effect of the other antihypertensive; may cause
hyperkalemia with potassium-sparing diuretics, potassium supplements; increase risk of lithium toxicity.
Side Effects:
GI: diarrhea, abdominal pain, nausea, constipation, dry mouth, dental pain
Nursing Responsibilities: